实用肝脏病杂志
實用肝髒病雜誌
실용간장병잡지
JOURNAL OF CLINICAL HEPATOLOGY
2013年
5期
407-410
,共4页
郑联坵%魏开鹏%潘兴南%魏梅娟%张小曼%王崇国
鄭聯坵%魏開鵬%潘興南%魏梅娟%張小曼%王崇國
정련구%위개붕%반흥남%위매연%장소만%왕숭국
肝细胞癌%高尔基体蛋白73%甲胎蛋白%诊断
肝細胞癌%高爾基體蛋白73%甲胎蛋白%診斷
간세포암%고이기체단백73%갑태단백%진단
Hepatocellular carcinoma%Golgi protein-73%Alpha-fetoprotein%Diagnosis
目的评价血清高尔基体蛋白73(GP73)在肝细胞癌(HCC)诊断中的价值。方法选择400例HCC、100例肝硬化(LC)、100例慢性乙型肝炎(CHB)患者和200例健康对照者(HC),分别采用ELISA和电化学发光法检测血清GP73和甲胎蛋白(AFP)水平;采用受试者工作特征曲线下面积( AUROC)评估两者对HCC的诊断效能。结果 HCC、CHB和LC患者血清GP73水平分别为243.6±163.1ng/ml、85.6±35.3ng/ml和81.9±36.4ng/ml,均显著高于健康对照组(78.2±33.9ng/ml,P<0.05),但在CHB和LC组及HC三组间无统计学差异;GP73和AFP的最佳诊断临界值分别为150.7ng/ml和19.7ng/ml,GP73的AUROC为0.846,灵敏性为69.2%,特异度为90.5%,均显著优于AFP(AUROC为0.828,灵敏性为57.6%,特异度为88.1%,P<0.05);GP73与AFP两者联合检测可以进一步提高对HCC的诊断准确性(AUROC为0.887,灵敏性为73.5%,特异度为88.0%);在AFP阴性与阳性的两组HCC患者中,GP73灵敏性和特异度无显著性差异。结论血清GP73对HCC的诊断效能高于AFP,两者联合检测可以进一步提高诊断效能。
目的評價血清高爾基體蛋白73(GP73)在肝細胞癌(HCC)診斷中的價值。方法選擇400例HCC、100例肝硬化(LC)、100例慢性乙型肝炎(CHB)患者和200例健康對照者(HC),分彆採用ELISA和電化學髮光法檢測血清GP73和甲胎蛋白(AFP)水平;採用受試者工作特徵麯線下麵積( AUROC)評估兩者對HCC的診斷效能。結果 HCC、CHB和LC患者血清GP73水平分彆為243.6±163.1ng/ml、85.6±35.3ng/ml和81.9±36.4ng/ml,均顯著高于健康對照組(78.2±33.9ng/ml,P<0.05),但在CHB和LC組及HC三組間無統計學差異;GP73和AFP的最佳診斷臨界值分彆為150.7ng/ml和19.7ng/ml,GP73的AUROC為0.846,靈敏性為69.2%,特異度為90.5%,均顯著優于AFP(AUROC為0.828,靈敏性為57.6%,特異度為88.1%,P<0.05);GP73與AFP兩者聯閤檢測可以進一步提高對HCC的診斷準確性(AUROC為0.887,靈敏性為73.5%,特異度為88.0%);在AFP陰性與暘性的兩組HCC患者中,GP73靈敏性和特異度無顯著性差異。結論血清GP73對HCC的診斷效能高于AFP,兩者聯閤檢測可以進一步提高診斷效能。
목적평개혈청고이기체단백73(GP73)재간세포암(HCC)진단중적개치。방법선택400례HCC、100례간경화(LC)、100례만성을형간염(CHB)환자화200례건강대조자(HC),분별채용ELISA화전화학발광법검측혈청GP73화갑태단백(AFP)수평;채용수시자공작특정곡선하면적( AUROC)평고량자대HCC적진단효능。결과 HCC、CHB화LC환자혈청GP73수평분별위243.6±163.1ng/ml、85.6±35.3ng/ml화81.9±36.4ng/ml,균현저고우건강대조조(78.2±33.9ng/ml,P<0.05),단재CHB화LC조급HC삼조간무통계학차이;GP73화AFP적최가진단림계치분별위150.7ng/ml화19.7ng/ml,GP73적AUROC위0.846,령민성위69.2%,특이도위90.5%,균현저우우AFP(AUROC위0.828,령민성위57.6%,특이도위88.1%,P<0.05);GP73여AFP량자연합검측가이진일보제고대HCC적진단준학성(AUROC위0.887,령민성위73.5%,특이도위88.0%);재AFP음성여양성적량조HCC환자중,GP73령민성화특이도무현저성차이。결론혈청GP73대HCC적진단효능고우AFP,량자연합검측가이진일보제고진단효능。
Objective To explore the accuracy of serum golgi protein-73 levels in diagnosis of patients with hepatocellular carcinoma (HCC). Methods 400 patients with HCC,200 with liver cirrhosis (LC),100 with chronic hepatitis B(CHB)and 100 healthy controls(HC)were collected in this study. Enzyme linked immunosorbent assay and electrochemiluminescence immunoassay were used to detect serum GP-73 and alpha fetal protein (AFP),respectively. The ability of GP73 and AFP in diagnosis of patients with HCC was evaluated by the area under the receiver operating characteristic curves (AUROC). Results Serum GP73 levels in patients with HCC, CHB and LC were 243.6±163.1ng/ml,85.6±35.3ng/ml and 81.9±36.4ng/ml,respectively,all of which were significantly higher than that in HC (78.2±33.9ng/ml,P<0.05);The optimal cut-off value of GP-73 and AFP for diagnosis of HCC were 150.7ng/ml and 19.7ng/ml,respectively and the AUROC of GP73 was 0.846,with a sensitivity of 69.2%and a specificity of 90.5%,which were both better than AFP(0.828,57.6% and 88.1%,respectively,P<0.05);When GP73 in combination with AFP,they led to an enhanced sensitivity of HCC detection up to 73.5% and the AUROC was 0.887;There was no difference in the positive rate of GP-73 between AFP positive or negative HCC subjects. Conclusion Serum GP-73 has a better accuracy than AFP for the diagnosis of HCC,and serum GP73 in com-bination with AFP might further increase the accuracy for HCC diagnosis.